tm
Seeing Is Believing
tm
Seeing Is Believing
Currently out of the existing stock ratings of Sumant Kulkarni, 152 are a BUY (86.86%), 23 are a HOLD (13.14%).
Analyst Sumant Kulkarni, currently employed at CANACCORD, carries an average stock price target met ratio of 41.02% that have a potential upside of 32.51% achieved within 168 days.
Sumant Kulkarni’s has documented 346 price targets and ratings displayed on 24 stocks. The coverage is on the Healthcare sector.
Most recent stock forecast was given on CMPS, Compass Pathways Plc at 18-Feb-2026.
Analyst best performing recommendations are on CARA (CARA THERAPEUTIC).
The best stock recommendation documented was for CARA (CARA THERAPEUTIC) at 6/13/2024. The price target of $10 was fulfilled within 4 days with a profit of $5.97 (37.38%) receiving and performance score of 93.46.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date of last PT
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Buy Since 26-Jun-2025
$30
$5.44 (22.15%)
$31
3 days ago
(26-Feb-2026)
0/6 (0%)
$5.03 (20.14%)
Buy Since 07-Aug-2015
$37
$12.44 (50.65%)
$35
3 days ago
(26-Feb-2026)
7/16 (43.75%)
$12.03 (48.18%)
671
Hold Since 03-Nov-2022
$24
$-0.56 (-2.28%)
$25
3 days ago
(26-Feb-2026)
18/22 (81.82%)
$-0.97 (-3.88%)
118
Hold Since 08-Oct-2025
$35
$10.44 (42.51%)
$29
6 days ago
(23-Feb-2026)
1/3 (33.33%)
$11.01 (45.89%)
35
Hold Since 09-May-2024
$35
$10.44 (42.51%)
$29
6 days ago
(23-Feb-2026)
11/16 (68.75%)
$11.01 (45.89%)
158
Which stock is Sumant Kulkarni is most bullish on?
Which stock is Sumant Kulkarni is most reserved on?
What Year was the first public recommendation made by Sumant Kulkarni?
